Stéphanie E B McArdle (S E B McArdle, Stéphanie E McArdle, Stephanie E McArdle, Stephanie E B McArdle)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Cancer immunology, immunotherapy : CII

Cancers

Biomedicines

Nanoscale advances

Nottingham Trent University

Royal Hallamshire Hospital (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nottingham Trent University Oct 01 2006

United Kingdom

Senior Research Scientist in Tumour Immunology :: The John van Geest Cancer Research Centre

Education History

Royal Hallamshire Hospital

United Kingdom

PHD :: Medical School

Manchester Metropolitan University

United Kingdom

BSC :: Applied Biology

Publications

Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Carles Puig-Saenz, Joshua R D Pearson, Jubini E Thomas, Stéphanie E B McArdle
A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer. Biomedicines 11 (8) (2023)
Kinana Habra, Joshua R D Pearson, Stéphanie E B McArdle
Robust formation of optimal single spheroids towards cost-effective in vitro three-dimensional tumor models. FEBS open bio (2023)
Kinana Habra, Joshua R D Pearson, P Le Vu, Carles Puig-Saenz, M J Cripps, M A Khan, M D Turner, C Sale, Stéphanie E B McArdle
Anticancer actions of carnosine in cellular models of prostate cancer. Journal of cellular and molecular medicine (2023)
Jayakumar Vadakekolathu, Elisabetta A M Verderio, Kirti Pandey, Barbara-Ann Guinn, Antoine Legrand, Amanda K Miles, Clare Coveney, Rochelle Ayala, Anthony Wayne Purcell, Stéphanie E B McArdle
Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy. Cancers 14 (16) (2022)
Pauline Le Vu, Jayakumar Vadakekolathu, Sarra Idri, Holly Nicholls, Manon Cavaignac, Stephen Reeder, Masood A Khan, Dennis Christensen, Alan Graham Pockley, Stéphanie E B McArdle
A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8 + T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice. Cancers 14 (8) (2022)
Kinana Habra, Robert H Morris, Stéphanie E B McArdle, Gareth W V Cave
Controlled release of carnosine from poly(lactic- co -glycolic acid) beads using nanomechanical magnetic trigger towards the treatment of glioblastoma. Nanoscale advances 4 (10) (2022)
Kinana Habra, Stéphanie E B McArdle, Robert H Morris, Gareth W V Cave
Synthesis and Functionalisation of Superparamagnetic Nano-Rods towards the Treatment of Glioblastoma Brain Tumours. Nanomaterials (Basel, Switzerland) 11 (9) (2021)
Erin G Shackleton, Haleema Yoosuf Ali, Masood Khan, Alan Graham Pockley, Stéphanie E B McArdle
Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer. Cancers 13 (5) (2021)
Divya Nagarajan, Stéphanie E B McArdle
Immune Landscape of Breast Cancers. Biomedicines 6 (1) (2018)

Stéphanie E B McArdle.css-eqlu8i{font-size:small;padding-left:4px;} (S E B McArdle, Stéphanie E McArdle, Stephanie E McArdle, Stephanie E B McArdle)

Publication Activity (10 Years)

Top Topics

Top Venues

Stéphanie E B McArdle (S E B McArdle, Stéphanie E McArdle, Stephanie E McArdle, Stephanie E B McArdle)